Geneos Wealth Management’s AdvisorShares Pure Cannabis ETF YOLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64K Sell
22,160
-12,650
-36% -$37.5K ﹤0.01% 1375
2026
Q1
$91.5K Sell
34,810
-16,050
-32% -$47.7K ﹤0.01% 1200
2025
Q4
$168K Buy
50,860
+47,100
+1,253% +$152K ﹤0.01% 978
2025
Q3
$13.3K Buy
+3,760
New +$10.5K ﹤0.01% 1868
2025
Q1
Sell
-220
Closed -$532 3160
2024
Q4
$532 Hold
220
﹤0.01% 2876
2024
Q3
$717 Hold
220
﹤0.01% 2505
2024
Q2
$741 Hold
220
﹤0.01% 2017
2024
Q1
$898 Hold
220
﹤0.01% 2046
2023
Q4
$664 Hold
220
﹤0.01% 2063
2023
Q3
$752 Hold
220
﹤0.01% 2060
2023
Q2
$565 Buy
+220
New +$597 ﹤0.01% 2059
2021
Q2
Sell
-641
Closed -$13K 3142
2021
Q1
$13K Sell
641
-1,047
-62% -$25.1K ﹤0.01% 2277
2020
Q4
$38K Buy
+1,688
New +$24K ﹤0.01% 1595

Other funds holding YOLO

Geneos Wealth Management's YOLO Position: Q2 2026 in Review

Geneos Wealth Management reduced its AdvisorShares Pure Cannabis ETF (YOLO) stake by 36% in Q2 2026, selling an estimated $37.5K and leaving 22,160 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Geneos Wealth Management first reported a position in YOLO in Q4 2020 and has held it in 13 quarters since. The position peaked at $168K in Q4 2025. 56 funds tracked by Wall St. Rank hold YOLO as of Q2 2026.

  • Geneos Wealth Management held 22,160 shares of AdvisorShares Pure Cannabis ETF worth $64K as of Q2 2026.
  • Geneos Wealth Management sold 12,650 AdvisorShares Pure Cannabis ETF shares in Q2 2026, an estimated $37.5K.
  • AdvisorShares Pure Cannabis ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1375 holding.
  • Geneos Wealth Management first reported a position in AdvisorShares Pure Cannabis ETF in Q4 2020 and has held it in 13 quarters since.
  • Geneos Wealth Management's AdvisorShares Pure Cannabis ETF position peaked at $168K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held AdvisorShares Pure Cannabis ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.